• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Brain Metabolic Correlates of the Off-Target Effects of Enzalutamide on the Central Nervous System of Patients with Advanced Prostate Cancer.

作者信息

Bauckneht Matteo, Fornarini Giuseppe, Di Raimondo Tania, Pardini Matteo, Donegani Maria Isabella, Banna Giuseppe Luigi, Di Maio Massimo, Morbelli Silvia

机构信息

IRCCS Ospedale Policlinico San Martino, Genova, Italy;

IRCCS Ospedale Policlinico San Martino, Genova, Italy.

出版信息

J Nucl Med. 2024 Aug 1;65(8):1327. doi: 10.2967/jnumed.124.267526.

DOI:10.2967/jnumed.124.267526
PMID:38604757
Abstract
摘要

相似文献

1
Brain Metabolic Correlates of the Off-Target Effects of Enzalutamide on the Central Nervous System of Patients with Advanced Prostate Cancer.
J Nucl Med. 2024 Aug 1;65(8):1327. doi: 10.2967/jnumed.124.267526.
2
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.全身扩散加权磁共振成像用于评估接受恩杂鲁胺治疗的转移性激素敏感性前列腺癌患者的骨反应率
Eur Urol. 2024 Sep;86(3):268-271. doi: 10.1016/j.eururo.2024.05.004. Epub 2024 May 20.
3
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial.恩杂鲁胺对比比卡鲁胺联合雄激素剥夺疗法治疗转移性激素敏感性前列腺癌男性患者的临床疗效：一项随机临床试验。
JAMA Netw Open. 2021 Jan 4;4(1):e2034633. doi: 10.1001/jamanetworkopen.2020.34633.
4
KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer.KIF15 介导的 AR 和 AR-V7 稳定促进前列腺癌对恩杂鲁胺的耐药性。
Cancer Res. 2021 Feb 15;81(4):1026-1039. doi: 10.1158/0008-5472.CAN-20-1965. Epub 2020 Dec 4.
5
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide.醋酸阿比特龙在恩杂鲁胺治疗后进展的转移性去势抵抗性前列腺癌患者中的临床活性。
Ann Oncol. 2013 Jul;24(7):1802-1807. doi: 10.1093/annonc/mdt138. Epub 2013 Apr 12.
6
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study.采用 F-FDG PET 参数对转移性前列腺癌全身肿瘤负荷进行定量评估，并与一线阿比特龙或恩杂鲁胺治疗后的总生存相关：一项单中心回顾性队列研究。
J Nucl Med. 2021 Aug 1;62(8):1050-1056. doi: 10.2967/jnumed.120.256602. Epub 2021 Jan 8.
7
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study.恩杂鲁胺联合放射治疗中危前列腺癌：一项 2 期研究。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1416-1422. doi: 10.1016/j.ijrobp.2021.02.027. Epub 2021 Feb 23.
8
Enzalutamide for the treatment of prostate cancer.恩杂鲁胺治疗前列腺癌。
Expert Opin Pharmacother. 2013 Apr;14(5):679-85. doi: 10.1517/14656566.2013.775251. Epub 2013 Feb 27.
9
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better?恩杂鲁胺与醋酸亮丙瑞林治疗非转移性激素敏感性前列腺癌：越早越好？
Future Oncol. 2024 Feb;20(4):163-166. doi: 10.2217/fon-2023-1019. Epub 2024 Feb 7.
10
Androgen receptor splice variants in the era of enzalutamide and abiraterone.恩杂鲁胺和阿比特龙时代的雄激素受体剪接变体
Horm Cancer. 2014 Oct;5(5):265-73. doi: 10.1007/s12672-014-0190-1. Epub 2014 Jul 22.

引用本文的文献

1
Cognitive outcomes in prostate cancer treatment: insights from the ODENZA trial and future considerations.前列腺癌治疗中的认知结果：来自ODENZA试验的见解及未来考量
Transl Androl Urol. 2025 Apr 30;14(4):864-867. doi: 10.21037/tau-2024-747. Epub 2025 Apr 15.
2
The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.基于前列腺特异性膜抗原（PSMA）的放射性配体疗法在激素敏感性前列腺癌中的作用。
Eur J Nucl Med Mol Imaging. 2025 Feb 12. doi: 10.1007/s00259-025-07083-8.